CONCORD BIOTECH LIMITED

CONCORDBIO

Small Cap | Pharmaceuticals
₹1135
-5 (-0.43%)

Stock price as on 15 May 2026 at 15:29 PM

Concord biotech limited share price update

As of the latest trading session, Concord Biotech Limited share price is currently at ₹1135, which is down by ₹-5 from its previous closing. Today the...

Concord Biotech Limited stock performance

Today’s low

₹1,112.7

Today’s high

₹1,149.4

₹1,135

52 week low

₹987

52 week high

₹2,150.4

₹1,135
Open
₹1,140.00
Previous close
₹1,140.00
Share volume
67,969
Total traded value (Lakh)
₹771.65
Upper circuit
₹1,368.00
Lower circuit
₹912.00

Concord Biotech Limited fundamentals

Market cap (Cr)
₹11,877.10
P/E ratio (TTM)
37.66
Book value per share
₹174.47
Beta
0.78
Return on equity
22.35%
Earnings per share (TTM)
₹30.36
Dividend yield
0.77%
Net profit/quarter (Cr)
₹67.78

Concord Biotech Limited technical summary

₹1135.3
-0.41 ▼
10
Bearish
6
Bullish
5 Day1,145
10 Day1,146
12 Day1,143.1
20 Day1,130.3
26 Day1,124.8
50 Day1,131.7
100 Day1,196.8
200 Day1,332.8
5 Day1,146.5
10 Day1,170.7
12 Day1,165.3
20 Day1,121.2
26 Day1,104.3
50 Day1,110.1
100 Day1,183.8
200 Day1,378.5

1140.13

PIVOT

First support
₹0.00
First resistance
₹0.00
Second support
₹0.00
Second resistance
₹0.00
Third support
₹0.00
Third resistance
₹0.00
RSI
51.9
ADX
39.25
MACD
18.31
Williams % R
-46.78
Commodity Channel Index (CCI)
12.8
Date
15 May 2026
Same day
30,651
Week
65,534
Month
1,36,324
1 year
0.79
3 years
0.7
Over 1 month
9.1%
Over 1 year
-25.57%
Over 3 months
-2.44%
Over 3 years
6.38%
Over 6 months
-24.42%
Over 6 years
0%

Investment Returns

Over 1 Month9.1%
Over 3 Months2.44%
Over 6 Months24.42%
Over 1 Year25.57%

Concord Biotech Limited Shareholding pattern


Public
38.9%
Promoter holdings
44.08%
FII
7.79%
DII
9.22%
Promoter shares
0%
Promoter sharesShareCategory

Sudhir Kumar Vaid

3,01,69,524 (28.84%)

Shareholding of Promoter and Promoter Group

Manju Vaid

99,87,636 (9.55%)

Shareholding of Promoter and Promoter Group

Nishtha Jhunjhunwaladiscretionary Trust

83,99,732 (8.03%)

Public Shareholding

Aryaman Jhunjhunwala Discretionary Trust

83,99,754 (8.03%)

Public Shareholding

Aryavir Jhunjhunwala Discretionary Trust

83,99,754 (8.03%)

Public Shareholding

Promoter sharesShareCategory
Sudhir Kumar Vaid3,01,69,524 (28.84%)Shareholding of Promoter and Promoter Group
Manju Vaid99,87,636 (9.55%)Shareholding of Promoter and Promoter Group
Nishtha Jhunjhunwaladiscretionary Trust83,99,732 (8.03%)Public Shareholding
Aryaman Jhunjhunwala Discretionary Trust83,99,754 (8.03%)Public Shareholding
Aryavir Jhunjhunwala Discretionary Trust83,99,754 (8.03%)Public Shareholding
Sudman Consultants Llp47,52,000 (4.54%)Shareholding of Promoter and Promoter Group
Government Pension Fund Global31,28,149 (2.99%)Public Shareholding
1575773 Ontario Inc20,92,325 (2%)Public Shareholding
Tata Aia Life Insurance Co Ltd Unit Linked Multi Cap Fund19,94,581 (1.91%)Public Shareholding
Dsp Small Cap Fund18,28,652 (1.75%)Public Shareholding
Axis Max Life Insurance Limited A/c Reversionary Bonus Participating - Equity15,87,162 (1.52%)Public Shareholding
Ravindra Raichand Dharamshi12,56,432 (1.2%)Public Shareholding
Chanakya Corporate Services Pvt Ltd11,63,833 (1.11%)Public Shareholding
Ohm Stock Broker Private Limited11,00,000 (1.05%)Public Shareholding
Ankur Sudhir Vaid5,86,520 (0.56%)Shareholding of Promoter and Promoter Group
Vaid Megha Ankur5,47,008 (0.52%)Shareholding of Promoter and Promoter Group
Sonal Kumra73,920 (0.07%)Shareholding of Promoter and Promoter Group

About CONCORD BIOTECH LIMITED

Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies. Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based bio pharma and one of the leading global developers and manufacturers of select fermentation

Parent Organisation

Indian Private

NSE Symbol

CONCORDBIO

Founded

1984

CONCORD BIOTECH LIMITED CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
03 Sept 202510.7Final03 Sept 2025Equity shares
21 Jun 20248.75Final22 Jun 2024Equity shares

View more stocks

What’s trending

All stocks

REMUS

REMUS PHARMACEUTICALS L

865.25
+144.2 (+20%)
HARDCAS

HARDCASTLE & WAUD MFG.CO.LTD.

877.8
+146.3 (+20%)
WAKEFIT

WAKEFIT INNOVATIONS LIMITED

143.75
+23.8 (+19.84%)
WAKEFIT

WAKEFIT INNOVATIONS LTD

143.25
+23.61 (+19.73%)
View all

Top gainers

ADANIENT

ADANI ENTERPRISES LIMITED

2716
+280.40 (+11.51%)
TMPV

TATA MOTORS PASS VEH LTD

356.55
+17.80 (+5.25%)
DRREDDY

DR. REDDY S LABORATORIES

1336.7
+33.10 (+2.54%)
INFY

INFOSYS LIMITED

1119
+24.00 (+2.19%)
View all

Top losers

HINDALCO

HINDALCO INDUSTRIES LTD

1067.5
-35.80 (-3.24%)
NESTLEIND

NESTLE INDIA LIMITED

1430.5
-29.10 (-1.99%)
TATASTEEL

TATA STEEL LIMITED

216.84
-4.29 (-1.94%)
ETERNAL

ETERNAL LIMITED

241.18
-4.64 (-1.89%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)